The race to conquer cancer is heating up, and the American Society of Clinical Oncology (ASCO) is leading the charge! ASCO has just announced the dates for its 2026 ASCO Breakthrough, a pivotal event for the global oncology community.
But here's the exciting part: ASCO is calling for submissions of cutting-edge oncology research, offering a platform for scientists to showcase their work on a global stage. This is a unique opportunity for researchers to present their findings and engage with international experts, potentially accelerating the translation of novel research into real-world impact.
The 2026 ASCO Breakthrough will be held from June 25 to 27 in Singapore, co-hosted by ASCO and the Singapore Society of Oncology, along with other Asia-Pacific collaborators. This meeting is a gateway for cancer care professionals to share their research with a diverse audience, fostering collaboration and the exchange of ideas across different healthcare systems and patient populations.
"ASCO Breakthrough is where the future of oncology unfolds," said Dr. Yun Yen, Program Committee Chair. "We invite researchers to submit abstracts and be part of a community that drives global progress against cancer." This event promises to be a catalyst for innovation, bringing together experts from various fields, including artificial intelligence, digital technology, and various cancer specialties.
And this is where it gets controversial: ASCO is accepting abstracts on a wide range of topics, from the latest in breast cancer research to central nervous system tumors and developmental therapeutics. But will this diverse agenda truly accelerate progress, or is it a case of 'jack of all trades, master of none'? The debate is open, and the oncology community is eager to see the impact of this inclusive approach.
The submission deadline is February 24, 2026, Eastern Time, with accepted abstracts published in the Journal of Clinical Oncology supplement. ASCO also offers fee waivers for professionals from low- and middle-income countries, ensuring accessibility and diversity in the research presented.
ASCO Breakthrough has a rich history, with the 2024 meeting attracting nearly 800 experts from over 35 countries. As the 2026 event approaches, the excitement builds, and the potential for groundbreaking discoveries looms large. Will this be the year that cancer research takes a giant leap forward? Only time will tell, but the stage is set for a remarkable journey.
For more information and to submit abstracts, visit breakthrough.asco.org. Join the conversation and be part of the movement to conquer cancer!
